Literature DB >> 6419573

Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure.

J A Franciosa, C L Leddy, M Wilen, D E Schwartz.   

Abstract

The cause of exercise intolerance in congestive heart failure is unclear. Hemodynamic and ventilatory responses were measured during symptomatic maximal upright bicycle exercise in 28 patients with chronic severe left ventricular failure who achieved a maximal oxygen uptake of only 12 +/- 4 ml/min/kg (+/- standard deviation). All patients reached anaerobic metabolism as the respiratory exchange ratio rose and arterial pH fell significantly. Pulmonary capillary wedge pressure increased from 20 +/- 10 mm Hg at rest to 38 +/- 9 mm Hg at peak exercise and cardiac index increased from 2.51 +/- 0.73 to 4.54 +/- 1.65 liters/min/m2 (both p less than 0.001). Systemic vascular resistance decreased, but pulmonary vascular resistance did not change during exercise. Despite the marked pulmonary venous hypertension at peak exercise, blood gases were unchanged (PaO2, 96 +/- 15 mm Hg; PaCO2, 35 +/- 7 mm Hg). Systemic arterial oxygen content increased from 16 +/- 2 to 17 +/- 2 vol% (p less than 0.01). Changes in pulmonary capillary wedge pressure did not correlate with changes in arterial oxygen content. Results were similar whether patients were limited by dyspnea or fatigue. Thus, exercise intolerance in patients with severe left ventricular failure is associated with marked elevation of pulmonary capillary wedge pressure and anaerobic metabolism without hypoxemia or altered carbon dioxide tension. These findings suggest that exercise ability in congestive heart failure is more dependent on cardiac output than on ventilatory consequences of pulmonary congestion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6419573     DOI: 10.1016/0002-9149(84)90696-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  33 in total

1.  Evaluation of exercise capacity using wave intensity in chronic heart failure with normal ejection fraction.

Authors:  Yoichi Takaya; Manabu Taniguchi; Motoaki Sugawara; Saori Nobusada; Kengo Kusano; Teiji Akagi; Hiroshi Ito
Journal:  Heart Vessels       Date:  2013-03       Impact factor: 2.037

Review 2.  Exercise training as therapy for chronic heart failure.

Authors:  N G Uren; D P Lipkin
Journal:  Br Heart J       Date:  1992-06

3.  Peak oxygen uptake. Myth and truth about an internationally accepted reference value.

Authors:  T Meyer; J Scharhag; W Kindermann
Journal:  Z Kardiol       Date:  2005-04

4.  Factors which alter the relationship between ventilation and carbon dioxide production during exercise in normal subjects.

Authors:  A L Clark; M Volterrani; M Piepoli; A J Coats
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

5.  Symptoms limiting exercise in chronic heart failure.

Authors:  D P Lipkin; P A Poole-Wilson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-19

Review 6.  The role of exercise testing in the evaluation and management of heart failure.

Authors:  D J Wright; L B Tan
Journal:  Postgrad Med J       Date:  1999-08       Impact factor: 2.401

7.  Physiological cardiac reserve: development of a non-invasive method and first estimates in man.

Authors:  G A Cooke; P Marshall; J K al-Timman; D J Wright; R Riley; R Hainsworth; L B Tan
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

8.  Relationship between exercise hyperpnea, hemodynamics, and blood gases before and during glyceryl trinitrate infusion in patients with exercise-induced elevation of pulmonary artery wedge pressure.

Authors:  L H Jørgensen; E Thaulow; H E Refsum
Journal:  Clin Cardiol       Date:  1997-09       Impact factor: 2.882

9.  Respiratory gas exchange in the assessment of patients with impaired ventricular function.

Authors:  D P Lipkin; J Perrins; P A Poole-Wilson
Journal:  Br Heart J       Date:  1985-09

10.  The measurement of extravascular lung density with SPECT imaging and its relationship with ventilatory abnormalities in patients with congestive heart failure.

Authors:  Eduardo S Darze; Kar-Lai Wong; Joseph R McClellan; Evan Loh; Luis I Araujo
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.